Clinical Trials
All Clinical Trials - Page 2 of 52
A complete, crawlable index of every tracked clinical trial of peptide compounds. Use the search browser at /trials for filtering, or page through the full list here.
- NCT07673900Phase 1Recruiting
Semaglutide Delivered Epi-Intradermally by Microarray Patch (VX-201) Versus Subcutaneous Administration in Healthy Overweight and Obese Participants
Semaglutide
- NCT07613437Phase 2Not Yet Recruiting
GLP-1 Receptor Agonist in Primary Intracerebral Hemorrhage: A Phase 2 Randomized Trial
Semaglutide
- NCT07046819Phase 2Recruiting
Tirzepatide in MetALD
Tirzepatide
- NCT07257484Phase 4Recruiting
Tirzepatide's Role in Postmenopausal HR+ Breast Cancer Survivors
Tirzepatide
- NCT07605247Phase 2Not Yet Recruiting
Tirzepatide in the Treatment of Endometrial Cancer
Tirzepatide
- NCT07444073N/ANot Yet Recruiting
Assessing Biological Aging in a Real-World Medical Weight Loss Program Using the LinAge2 Clinical Clock
Tirzepatide
- NCT07423481N/ANot Yet Recruiting
Weight Trajectories and Predictive Factors After Semaglutide in Patients With Grade 3 and Complicated Obesity
Semaglutide
- NCT06934655Phase 3Not Yet Recruiting
Early Re-Initiation of Semaglutide Post Sleeve Gastrectomy in Youth
Semaglutide
- NCT07570810N/ANot Yet Recruiting
Efficacy, Safety, and Tolerability of CS0159 Combined With Semaglutide in MAFLD Patients With Obesity and T2DM
Semaglutide
- NCT07642700N/ANot Yet Recruiting
GnRH Agonist Pretreatment in Persistent Chronic Endometritis Undergoing FET
Gonadorelin
- NCT07387796N/ARecruiting
Clinical and Neurobehavioral Changes With Weight Loss Drug Discontinuation and Reinitiation
Tirzepatide
- NCT07554638Phase 4Not Yet Recruiting
Incretin Therapies in Obesity-related HFpEF
Tirzepatide
- NCT07621640N/ANot Yet Recruiting
Brown Adipose Tissue as a Mechanistic Determinant of Semaglutide Treatment Response in Obesity (BAT-Sema Study)
Semaglutide
- NCT07282769Phase 2Not Yet Recruiting
Semaglutide (Wegovy) Treatment for Trichotillomania
Semaglutide
- NCT07602699Phase 2Recruiting
Multi-Site Trial of Tirzepatide for Smoking Cessation
Tirzepatide
- NCT07607587Phase 1Recruiting
Evaluation of the Tolerability of Cagrilintide in Participants Not Tolerating GLP-1-RA Therapies Due to Gastrointestinal Adverse Events
Cagrilintide
- NCT07657676Phase 4Not Yet Recruiting
Effect of Mazdutide on Coronary Plaque in Patients With Coronary Atherosclerosis and Overweight or Obesity
Mazdutide
- NCT07650149N/ARecruiting
Genetic, Microbiological and Behavioral Factors in Obesity
Tirzepatide
- NCT07527910Phase 2Recruiting
A Phase 2a Study of ALN-PNP With and Without a GLP1R Agonist in Adult Patients With Homozygous PNPLA3-Related MASLD
Tirzepatide
- NCT07564414Phase 3Recruiting
A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose Weight
Semaglutide
- NCT07027124Phase 2Recruiting
Neoadjuvant ADT + Darolutamide With Pembrolizumab, Followed by Adjuvant Pembrolizumab in Molecularly Stratified High-Risk Prostate Cancer
Gonadorelin
- NCT07559500Phase 1Recruiting
Tirzepatide s Dopaminergic Effects in Alcohol Use Disorders (AUD)
Tirzepatide
- NCT07400107Phase 3Not Yet Recruiting
AMAZE 8: A Research Study Investigating How Well the Medicine NNC0487-0111 Compared to Semaglutide Helps People With Excess Body Weight and Type 2 Diabetes Lose Weight
Semaglutide
- NCT07605052Phase 1Not Yet Recruiting
A Research Study to Compare Blood Levels of Two Different Versions of Cagrilintide in Adults With Excess Body Weight
Cagrilintide
- NCT07284511Phase 2/Phase 3Recruiting
A Clinical Trial Using Tirzepatide to Help Adults With Type 1 Diabetes Automatically Control Their Blood Sugar
Tirzepatide
- NCT07586865Phase 2Not Yet Recruiting
Recombinant Human Thymosin Beta 4 for Injection(NL005) for Acute Myocardial Infarction
TB-500
- NCT07597018Phase 1Recruiting
A Research Study to Compare Blood Levels of Cagrilintide After Multiple Doses of Different Versions of Cagrilintide in Adults With Overweight or Obesity
Semaglutide
- NCT07620067N/ARecruiting
GnRH for Luteal Support - Mechanism of Action
Gonadorelin
- NCT07574723N/ANot Yet Recruiting
Tirzepatide Titration to Reduce Side Effects in Individuals With Obesity
Tirzepatide
- NCT06726577Phase 1/Phase 2Recruiting
TP04HN106 in the Treatment of Patients With Amyotrophic Lateral Sclerosis
Liraglutide
- NCT07633639N/ARecruiting
GLP-1 Therapy After Bariatric Surgery in Chinese Patients With Obesity
Tirzepatide
- NCT07179120Phase 2Not Yet Recruiting
Can Fat-Burning Shots Boost Fertility? Comparing Weight-Loss Injections vs. Healthy Habits for Obese Men With Low Sperm Health
Tirzepatide
- NCT06546384N/ANot Yet Recruiting
GLP-1 RA on Alcohol Consumption, Metabolism and Liver Parameters in Patients With Obesity and Fatty Liver Disease
Semaglutide
- NCT07487103Phase 3Not Yet Recruiting
Efficacy and Safety of QLG1091 vs Rybelsus as add-on to Metformin in Subjects With Type 2 Diabetes
Semaglutide
- NCT07301437Phase 4Not Yet Recruiting
RWS of of Liraglutide Alone and in Combination With Orlistat for Weight Loss in Overweight/Obese Patients.
Liraglutide
- NCT07567378N/ANot Yet Recruiting
CARTIZ Registry: Cartilage, Arthropathy and Imaging Under Tirzepatide in Zone-stratified Cohorts - A Four-Institute Mexican Observational Registry
Tirzepatide
- NCT07537088Phase 4Not Yet Recruiting
Efficacy and Safety of Triple Therapy With Dulaglutide, SGLT2 Inhibitors, and Finerenone in Chinese Adults With Type 2 Diabetes and Chronic Kidney Disease
Dulaglutide
- NCT07588984N/ANot Yet Recruiting
GLP-1 Medication & Behavioral Health Programs on Weight & Metabolic Outcomes: FLOURISH and THRIVE Prospective Cohort Study
Tirzepatide
- NCT07555730Phase 4Not Yet Recruiting
AI-assisted Multi-domain Lifestyle Versus Tirzepatide for Weight Loss Maintenance in Adults With Type 2 Diabetes (AIM-MAINTAIN)
Tirzepatide
- NCT07523633Phase 2Recruiting
Effect of Semaglutide on Cannabis Use in Adults With Cannabis Use Disorder
Semaglutide
- NCT07502508Phase 2Recruiting
Phase 2 Trial of Icovamenib in Participants With Type 2 Diabetes Mellitus Who Are Not Achieving Glycemic Targets While Using GLP-1-Based Therapy
Semaglutide
- NCT07599046N/ANot Yet Recruiting
Fecal Microbiota Transplantation (FMT) Combined With Calorie-Restricted Diet and Semaglutide in Patients With Obesity and Type 2 Diabetes
Semaglutide
- NCT07557953Phase 1Recruiting
A Research Study Looking Into How Cagrilintide Influences Food Intake and Appetite in People With Overweight or Obesity
Cagrilintide
- NCT07497399Phase 2Recruiting
Targeting Agonists of Glucagon-like Peptide-1 Receptor for Multiple Sclerosis
Exenatide
- NCT07065552EARLY_Phase 1Recruiting
Tirzepatide in Obesity-Driven Endometrial Cancer
Tirzepatide
- NCT07581145Phase 3Recruiting
Effect of Semaglutide on Healing of Foot Ulcers in Type 2 Diabetes Patients
Semaglutide
- NCT07228741Phase 2Recruiting
Resistance Exercise and Incretin Mimetic for Cardiometabolic Health in Survivors of ALL With Obesity
Tirzepatide
- NCT07455903Phase 2Recruiting
Assessing Efficacy of Neoadjuvant ADT in Localized High-Risk Prostate Cancer Patients Utilizing 18F-Flotufolastat PSMA PET/CT
Gonadorelin
- NCT07469800Phase 3Recruiting
Efficacy and Safety of IBI362 in Hypertensive Patients With Overweight/Obesity
Mazdutide
- NCT07653412N/ARecruiting
Precision Obesity Medicine: Genetic Prediction of Response to GLP-1/GIP Agonists.
Tirzepatide